20,000
Participants
Start Date
May 6, 2025
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
Blood pressure monitor
In the trial group, atrial fibrillation screening will be integrated into blood pressure measurements using the BP77A1T electronic blood pressure monitor (Omron Healthcare, Kyoto, Japan).
Single-lead ECG
In the control group, a single-lead ECG will be recorded for 30s with a handheld ECG for atrial fibrillation detection. Each ECG rhythm strip will be reviewed and analyzed by a cardiologist from the research team.
Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai 200025, Shanghai
Shanghai Jiao Tong University School of Medicine
OTHER